Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | 12-2017 | |
| Sales | 12,281 | 13,166 | 0 | 0 |
| Gross Profit | 12,281 | 13,166 | N/A | N/A |
| Operating Expenses | 22,842 | 23,602 | 0 | 0 |
| Operating Income | -10,561 | -10,436 | N/A | N/A |
| Interest Expense | 28 | 30 | 0 | 0 |
| Other Income | 470 | 335 | 0 | 0 |
| Pre-tax Income | -10,119 | -10,131 | 0 | 0 |
| Net Income Continuous | -10,119 | -10,131 | N/A | N/A |
| Net Income | $-10,119 | $-10,131 | $N/A | $N/A |
| EPS Basic Total Ops | -4.85 | -4.84 | N/A | N/A |
| EPS Basic Continuous Ops | -3.72 | -3.83 | N/A | N/A |
| EPS Diluted Total Ops | -4.85 | -4.84 | N/A | N/A |
| EPS Diluted Continuous Ops | -3.72 | -3.83 | N/A | N/A |
| EBITDA(a) | $-9,838 | $-9,643 | $N/A | $N/A |